Nevrargenics Ltd.
www.nevrargenics.comOur vision is to employ new dual-acting retinoic acid receptor modulators (RAR-M) as the basis for developing a new rational effective treatment approach for ALS and meet that unmet need. In the longer term, we see a great opportunity to use our IP from the ALS arena to move on to target the wider range of neurodegenerative diseases.
Read more
Our vision is to employ new dual-acting retinoic acid receptor modulators (RAR-M) as the basis for developing a new rational effective treatment approach for ALS and meet that unmet need. In the longer term, we see a great opportunity to use our IP from the ALS arena to move on to target the wider range of neurodegenerative diseases.
Read more
Country
City (Headquarters)
Durham
Industry
Employees
1-10
Founded
2019
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Operations Officer and Company Secretary
Email ****** @****.comPhone (***) ****-****
Technologies
(1)
Reach decision makers at Nevrargenics Ltd.
Free credits every month!
Nevrargenics Ltd. FAQ
Durham, United Kingdom
Biotechnology Research
